Global Therapeutic Proteins and Oral Vaccines Market Research Report 2024(Status and Outlook)

Global Therapeutic Proteins and Oral Vaccines Market Research Report 2024(Status and Outlook)



Report Overview:

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.

The Global Therapeutic Proteins and Oral Vaccines Market Size was estimated at USD 450.92 million in 2023 and is projected to reach USD 636.03 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.

This report provides a deep insight into the global Therapeutic Proteins and Oral Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Proteins and Oral Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Proteins and Oral Vaccines market in any manner.

Global Therapeutic Proteins and Oral Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott

Amgen

Biogen

Eli Lilly and Company

Roche

Johnson and Johnson

Merck

Novo Nordisk

Pfizer

Sanofi

Serum Institute of India

Emergent Biosolutions

TransAlgae

MigVax

Lumen Bioscience

Market Segmentation (by Type)

Therapeutic Proteins

Oral Vaccines

Market Segmentation (by Application)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Therapeutic Proteins and Oral Vaccines Market

Overview of the regional outlook of the Therapeutic Proteins and Oral Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Proteins and Oral Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Therapeutic Proteins and Oral Vaccines
1.2 Key Market Segments
1.2.1 Therapeutic Proteins and Oral Vaccines Segment by Type
1.2.2 Therapeutic Proteins and Oral Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Therapeutic Proteins and Oral Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Therapeutic Proteins and Oral Vaccines Market Competitive Landscape
3.1 Global Therapeutic Proteins and Oral Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Proteins and Oral Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Proteins and Oral Vaccines Sales Sites, Area Served, Product Type
3.6 Therapeutic Proteins and Oral Vaccines Market Competitive Situation and Trends
3.6.1 Therapeutic Proteins and Oral Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Proteins and Oral Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Therapeutic Proteins and Oral Vaccines Industry Chain Analysis
4.1 Therapeutic Proteins and Oral Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Therapeutic Proteins and Oral Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Therapeutic Proteins and Oral Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Proteins and Oral Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Proteins and Oral Vaccines Price by Type (2019-2024)
7 Therapeutic Proteins and Oral Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Proteins and Oral Vaccines Market Sales by Application (2019-2024)
7.3 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Proteins and Oral Vaccines Sales Growth Rate by Application (2019-2024)
8 Therapeutic Proteins and Oral Vaccines Market Segmentation by Region
8.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.1 Global Therapeutic Proteins and Oral Vaccines Sales by Region
8.1.2 Global Therapeutic Proteins and Oral Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Proteins and Oral Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Proteins and Oral Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Proteins and Oral Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Proteins and Oral Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott
9.1.1 Abbott Therapeutic Proteins and Oral Vaccines Basic Information
9.1.2 Abbott Therapeutic Proteins and Oral Vaccines Product Overview
9.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Therapeutic Proteins and Oral Vaccines SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Amgen
9.2.1 Amgen Therapeutic Proteins and Oral Vaccines Basic Information
9.2.2 Amgen Therapeutic Proteins and Oral Vaccines Product Overview
9.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Therapeutic Proteins and Oral Vaccines SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Biogen
9.3.1 Biogen Therapeutic Proteins and Oral Vaccines Basic Information
9.3.2 Biogen Therapeutic Proteins and Oral Vaccines Product Overview
9.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product Market Performance
9.3.4 Biogen Therapeutic Proteins and Oral Vaccines SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Eli Lilly and Company
9.4.1 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Basic Information
9.4.2 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Overview
9.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Market Performance
9.4.4 Eli Lilly and Company Business Overview
9.4.5 Eli Lilly and Company Recent Developments
9.5 Roche
9.5.1 Roche Therapeutic Proteins and Oral Vaccines Basic Information
9.5.2 Roche Therapeutic Proteins and Oral Vaccines Product Overview
9.5.3 Roche Therapeutic Proteins and Oral Vaccines Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Basic Information
9.6.2 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Overview
9.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Merck
9.7.1 Merck Therapeutic Proteins and Oral Vaccines Basic Information
9.7.2 Merck Therapeutic Proteins and Oral Vaccines Product Overview
9.7.3 Merck Therapeutic Proteins and Oral Vaccines Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 Novo Nordisk
9.8.1 Novo Nordisk Therapeutic Proteins and Oral Vaccines Basic Information
9.8.2 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Overview
9.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Market Performance
9.8.4 Novo Nordisk Business Overview
9.8.5 Novo Nordisk Recent Developments
9.9 Pfizer
9.9.1 Pfizer Therapeutic Proteins and Oral Vaccines Basic Information
9.9.2 Pfizer Therapeutic Proteins and Oral Vaccines Product Overview
9.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
9.10 Sanofi
9.10.1 Sanofi Therapeutic Proteins and Oral Vaccines Basic Information
9.10.2 Sanofi Therapeutic Proteins and Oral Vaccines Product Overview
9.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Serum Institute of India
9.11.1 Serum Institute of India Therapeutic Proteins and Oral Vaccines Basic Information
9.11.2 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Overview
9.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Market Performance
9.11.4 Serum Institute of India Business Overview
9.11.5 Serum Institute of India Recent Developments
9.12 Emergent Biosolutions
9.12.1 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Basic Information
9.12.2 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Overview
9.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Market Performance
9.12.4 Emergent Biosolutions Business Overview
9.12.5 Emergent Biosolutions Recent Developments
9.13 TransAlgae
9.13.1 TransAlgae Therapeutic Proteins and Oral Vaccines Basic Information
9.13.2 TransAlgae Therapeutic Proteins and Oral Vaccines Product Overview
9.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product Market Performance
9.13.4 TransAlgae Business Overview
9.13.5 TransAlgae Recent Developments
9.14 MigVax
9.14.1 MigVax Therapeutic Proteins and Oral Vaccines Basic Information
9.14.2 MigVax Therapeutic Proteins and Oral Vaccines Product Overview
9.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product Market Performance
9.14.4 MigVax Business Overview
9.14.5 MigVax Recent Developments
9.15 Lumen Bioscience
9.15.1 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Basic Information
9.15.2 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Overview
9.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Market Performance
9.15.4 Lumen Bioscience Business Overview
9.15.5 Lumen Bioscience Recent Developments
10 Therapeutic Proteins and Oral Vaccines Market Forecast by Region
10.1 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast
10.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Region
10.2.4 South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Proteins and Oral Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Proteins and Oral Vaccines by Type (2025-2030)
11.1.2 Global Therapeutic Proteins and Oral Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Proteins and Oral Vaccines by Type (2025-2030)
11.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Proteins and Oral Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Proteins and Oral Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings